Correction to “A LC–MS/MS Method for the Simultaneous Determination of 6‐Cyanodopamine, 6‐Nitrodopamine, 6‐Nitrodopa, 6‐Nitroadrenaline and 6‐Bromodopamine in Human Plasma and Its Clinical Application in Patients With Chronic Kidney Disease”

Documenti analoghi

• Simultaneous Determination of Atezolizumab and Bevacizumab by LC–MS/MS in Rat Plasma and Its Application to a Pharmacokinetic Study
  di: Sudha Divya Madhuri Kallam, et al.
  Pubblicazione: (2025)
• A Simple and Sensitive LC‐MS/MS Method for the Determination of Mobocertinib and Its Metabolite Desmethyl‐Mobocertinib in Human Plasma and Its Application to Clinical Pharmacokinetic Study
  di: Fan Tang, et al.
  Pubblicazione: (2025)
• A Simple, Sensitive, and Stable LC–MS/MS Method for the Simultaneous Determination and Pharmacokinetic Study of Dapagliflozin and Its Metabolite D3OG in Human Plasma
  di: Ancheng Gu, et al.
  Pubblicazione: (2025)
• A Validated Quantitative LC–MS/MS Method for Determination of Deucravacitinib in Rat Plasma and Its Application to a Pharmacokinetic Study
  di: Pottabattula Mahesh, et al.
  Pubblicazione: (2025)
• Quantitation of Niraparib in Human Plasma by LC‐MS/MS
  di: Tien V. Le, et al.
  Pubblicazione: (2025)